Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors - Concepedia

Concepedia

Publication | Open Access

Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors

DOI Full Paper Access

75

Citations

29

References

2021

Year

Corey C. Foster, Marcus Couey, Sara Kochanny, Arun Khattri, Rajesh Acharya, Yi‐Hung Carol Tan, Ryan J. Brisson, Rom S. Leidner, Tanguy Y. Seiwert

Abstract

The development of irAEs was strongly associated with an ICI benefit, including overall response, PFS, and OS, in 2 separate cohorts of patients with recurrent/metastatic HNC.

References

	Year	Citations

Page 1